MediWound Ltd. maintains its primary corporate headquarters, advanced research laboratories, and specialized biopharmaceutical manufacturing facilities in Yavne, Israel. From this central operational hub, the company manages international clinical trials, regulatory affairs, quality assurance protocols, and global commercial partnerships tailored to advance its enzymatic wound care pipeline.